Cryoablation-Assisted Surgery for Kidney Cancer
(RCAPN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Patients with renal masses eligible to partial nephrectomy often require arterial ischemia to control or prevent blood loss during this surgical procedure. This study aims to determine the safety and efficacy of renal cryoablation at the tumor bed, as a substitute measure or technique vs total or selective arterial renal ischemia.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is cryoablation-assisted surgery for kidney cancer safe?
How is Cryoablation Assisted Partial Nephrectomy different from other kidney cancer treatments?
Cryoablation Assisted Partial Nephrectomy is unique because it combines cryoablation (freezing the tumor to kill cancer cells) with partial nephrectomy (surgically removing part of the kidney), offering a minimally invasive option that may help preserve more kidney function compared to traditional surgery alone.678910
What data supports the effectiveness of the treatment Cryoablation Assisted Partial Nephrectomy for kidney cancer?
Who Is on the Research Team?
FERNANDO J BIANCO, MD
Principal Investigator
Urological research Network
Are You a Good Fit for This Trial?
This trial is for individuals aged 45-90 with kidney tumors that are less than 7 cm large and mostly on the outside of the kidney. It's not suitable for those who've had previous kidney surgery or have metastatic disease, where cancer has spread to other parts of the body.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Patients undergo cryotherapy-assisted partial nephrectomy to manage renal masses without arterial ischemia.
Follow-up
Participants are monitored for safety, efficacy, and oncological control, including imaging studies at fixed intervals.
Long-term Monitoring
Participants are evaluated for survival, CKD progression, and incidence of metastatic disease over a 10-year period.
What Are the Treatments Tested in This Trial?
Interventions
- Cryoablation Assisted Partial Nephrectomy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Urological Research Network, LLC
Lead Sponsor